Loading...
XSTODIGN
Market cap6mUSD
Dec 23, Last price  
0.93SEK
1D
6.32%
1Q
-2.12%
Jan 2017
-92.72%
IPO
-74.77%
Name

Dignitana AB

Chart & Performance

D1W1MN
XSTO:DIGN chart
P/E
—
P/S
0.87
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
11.36%
Rev. gr., 5y
20.59%
Revenues
86m
+17.90%
2,104,0001,721,0003,943,0005,528,0008,969,00010,097,00020,334,0004,749,0008,902,00022,941,00033,742,00040,699,00046,630,00057,073,00072,995,00086,063,000
Net income
-17m
L-22.52%
-13,725,000-10,774,000-21,556,000-3,664,000-13,230,000-16,560,000-10,914,000-16,569,000-32,269,000-42,600,000-26,021,000-38,035,000-54,928,000-43,086,000-22,411,000-17,363,000
CFO
-6m
L-68.38%
1,573,000-14,438,000-15,958,000-8,883,000-11,869,000-16,313,000-2,930,000-21,421,000-30,605,000-33,467,000-20,632,000-27,334,000-21,303,000-43,873,000-18,164,000-5,744,000
Earnings
Feb 20, 2025

Profile

Dignitana AB (publ), a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. The company was incorporated in 2007 is headquartered in Lund, Sweden.
URL
https://dignitana.com/
IPO date
Jun 18, 2009
Employees
27
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
86,063
17.90%
72,995
27.90%
57,073
22.40%
Cost of revenue
27,092
26,618
50,764
Unusual Expense (Income)
NOPBT
58,971
46,377
6,309
NOPBT Margin
68.52%
63.53%
11.05%
Operating Taxes
135
15
10
Tax Rate
0.23%
0.03%
0.16%
NOPAT
58,836
46,362
6,299
Net income
(17,363)
-22.52%
(22,411)
-47.99%
(43,086)
-21.56%
Dividends
Dividend yield
Proceeds from repurchase of equity
684
23,715
BB yield
-0.45%
-6.99%
Debt
Debt current
13,027
9,653
7,762
Long-term debt
6,077
8,614
15,828
Deferred revenue
Other long-term liabilities
409
187
69
Net debt
12,668
9,223
9,089
Cash flow
Cash from operating activities
(5,744)
(18,164)
(43,873)
CAPEX
(4,597)
(3,221)
(10,556)
Cash from investing activities
(3,796)
(3,130)
(10,556)
Cash from financing activities
7,039
15,030
(7,321)
FCF
65,979
49,484
3,509
Balance
Cash
6,027
8,869
14,501
Long term investments
409
175
Excess cash
2,133
5,394
11,647
Stockholders' equity
(239,286)
7,047
6,506
Invested Capital
266,063
37,310
48,339
ROIC
38.79%
108.26%
9.76%
ROCE
220.23%
108.60%
11.50%
EV
Common stock shares outstanding
69,452
66,130
65,059
Price
2.18
-57.50%
5.13
-41.44%
8.76
6.31%
Market cap
151,405
-55.37%
339,248
-40.47%
569,918
25.28%
EV
164,073
805,797
975,031
EBITDA
74,083
60,176
19,032
EV/EBITDA
2.21
13.39
51.23
Interest
1,841
1,993
1,529
Interest/NOPBT
3.12%
4.30%
24.24%